These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15027854)

  • 1. Synthesis, structure-activity relationships, and mechanism of drug resistance of D- and L-beta-3'-fluoro-2',3'-unsaturated-4'-thionucleosides as anti-HIV agents.
    Zhu W; Chong Y; Choo H; Mathews J; Schinazi RF; Chu CK
    J Med Chem; 2004 Mar; 47(7):1631-40. PubMed ID: 15027854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
    Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
    J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, anti-HIV activity, and molecular mechanism of drug resistance of L-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides.
    Choo H; Chong Y; Choi Y; Mathew J; Schinazi RF; Chu CK
    J Med Chem; 2003 Jan; 46(3):389-98. PubMed ID: 12540238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antiviral activity, and mechanism of drug resistance of D- and L-2',3'-didehydro-2',3'-dideoxy-2'-fluorocarbocyclic nucleosides.
    Wang J; Jin Y; Rapp KL; Bennett M; Schinazi RF; Chu CK
    J Med Chem; 2005 Jun; 48(11):3736-48. PubMed ID: 15916425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationships, and drug resistance of beta-d-3'-fluoro-2',3'-unsaturated nucleosides as anti-HIV Agents.
    Zhou W; Gumina G; Chong Y; Wang J; Schinazi RF; Chu CK
    J Med Chem; 2004 Jun; 47(13):3399-408. PubMed ID: 15189036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of dioxolane nucleosides against 3TC resistant M184V mutant HIV.
    Chong Y; Chu CK
    Antiviral Res; 2004 Jul; 63(1):7-13. PubMed ID: 15196815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-Fluoro-4'-thio-2',3'-unsaturated nucleosides: anti-HIV activity, resistance profile, and molecular modeling studies.
    Chong Y; Choo H; Schinazi RF; Chu CK
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):611-5. PubMed ID: 14565238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistance.
    Wang J; Jin Y; Rapp KL; Schinazi RF; Chu CK
    J Med Chem; 2007 Apr; 50(8):1828-39. PubMed ID: 17373782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.
    Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE
    J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective synthesis and antiviral activity of D-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides.
    Chong Y; Choo H; Choi Y; Mathew J; Schinazi RF; Chu CK
    J Med Chem; 2002 Oct; 45(22):4888-98. PubMed ID: 12383014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
    Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
    J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 2',3'-unsaturation on the antiviral activity of anti-HIV nucleosides against 3TC-resistant mutant (M184V).
    Choo H; Chong Y; Chu CK
    Bioorg Med Chem Lett; 2003 Jun; 13(12):1993-6. PubMed ID: 12781181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV activity of (-)-(2R,4R)-1- (2-hydroxymethyl-1,3-dioxolan-4-yl)-thymine against drug-resistant HIV-1 mutants and studies of its molecular mechanism.
    Chu CK; Yadav V; Chong YH; Schinazi RF
    J Med Chem; 2005 Jun; 48(12):3949-52. PubMed ID: 15943470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.
    Piscitelli F; Coluccia A; Brancale A; La Regina G; Sansone A; Giordano C; Balzarini J; Maga G; Zanoli S; Samuele A; Cirilli R; La Torre F; Lavecchia A; Novellino E; Silvestri R
    J Med Chem; 2009 Apr; 52(7):1922-34. PubMed ID: 19281225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-HIV and anti-HBV activities of 2'-fluoro-2', 3'-unsaturated L-nucleosides.
    Lee K; Choi Y; Gullen E; Schlueter-Wirtz S; Schinazi RF; Cheng YC; Chu CK
    J Med Chem; 1999 Apr; 42(7):1320-8. PubMed ID: 10197975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine (dOTC).
    Richar N; Quan Y; Salomon H; Hsu M; Bedard J; Harrigan PR; Rando R; Mansour T; Bowlin TL; Wainberg MA
    Antivir Ther; 1999; 4(3):171-7. PubMed ID: 12731757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
    Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
    J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral evaluation of 6-(trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of HIV drugs emivirine and GCA-186.
    El-Brollosy NR; Sørensen ER; Pedersen EB; Sanna G; La Colla P; Loddo R
    Arch Pharm (Weinheim); 2008 Jan; 341(1):9-19. PubMed ID: 18161905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.
    Venkatachalam TK; Mao C; Uckun FM
    Biochem Pharmacol; 2004 May; 67(10):1933-46. PubMed ID: 15130770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants.
    Herschhorn A; Lerman L; Weitman M; Gleenberg IO; Nudelman A; Hizi A
    J Med Chem; 2007 May; 50(10):2370-84. PubMed ID: 17458947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.